Oct. 14, 2021, Rochester, NY– In light of the health disparities in oncology, GRYT Health (“grit”), an oncology solutions company that was started and run by cancer survivors, and Bristol Myers Squibb, have partnered to launch Diversity in Oncology, a virtual platform available at www.diversityinoncology.com
Digital oncology organization growth allows for new employees and promotions, including the appointment of Sheila Thorne, president and chief executive officer, Multicultural Healthcare Marketing Group, LLC, to its Board of Directors.
Today, Bristol Myers Squibb and GRYT Health unveiled the “Advocacy Exchange,” an evolution of the existing COVID Advocacy Exchange, an enduring community built to support patient advocacy organizations by providing access to educational resources, encouraging ongoing dialogue, and sharing best practices among participants.
GRYT Health is proud to announce the recent publication of the paper "Assessment of Bone Health Education in U.S. Multiple Myeloma and Solid Tumor Patients at Risk for Skeletal-Related Events" in Cancer Management and Research.
On February 4, 2021, GRYT (“grit”) Health, a digital oncology company that empowers people to be in charge of their own health, is celebrating its five-year anniversary.
GRYT Health and Bristol Myers Squibb Team Up to Launch COVID Advocacy Exchange for Patient Advocates
Over the last two years in collaboration with Amgen, GRYT (“grit”) Health, a digital oncology company that empowers people to be in charge of their own health, has conducted the Bone Health Education Needs Assessment (BEACON) Study with more than 250 cancer patients at high risk for cancer-related bone complications.
